J&J International Baby, Beauty Lines Could Lead Trimming 10% Of Consumer Portfolio

J&J plans to cut 10% of its consumer health portfolio, with most divestitures in the baby and beauty care segments outside the US. It plans to focus on growing “stronghold” categories of skin health and self care, including Aveeno and Tylenol.

Piz Buin sunscreen line
Piz Buin moisturing products J&J markets in international markets are among the SKUs the firm could prioritze divesting in its planned consumer business trimming.

More from Earnings

More from Business